Chelsea Cooper

Chelsea Cooper is an experienced executive in the pharmaceutical and biotechnology sectors, currently serving as the Executive Director of Medical Affairs at Mirador Global LP since February 2016. Chelsea has comprehensive expertise in drug commercialization assessment, launch planning services, and has held significant roles such as Managing Director at Global Medical Affairs Consultants and Director of Scientific Services at Evolution Medical Communications LLC. Prior to these positions, Chelsea contributed to AstraZeneca as a Global Medical Affairs Manager, focusing on target product profiles and competitive analysis. Chelsea's career began with a PharmD from Campbell University, followed by roles in disease state management and drug information, showcasing a strong foundation in clinical and commercial strategies throughout the pharmaceutical industry.